2013-04-02T17:52:00
RESEARCH: Researchers from the Royal Liverpool and Broadgreen University Hospitals Trust Royal have been pioneering an innovative new technique to treat patients with rare liver cancer hepatocellular carcinoma (HCC) that can extend their life expectancy and reduce side effects.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud